Filing Details
- Accession Number:
- 0000711377-13-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-20 17:16:16
- Reporting Period:
- 2013-08-15
- Filing Date:
- 2013-08-20
- Accepted Time:
- 2013-08-20 17:16:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189021 | Edward Bradley | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-08-15 | 4,499 | $18.19 | 126,186 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-08-20 | 4,499 | $53.80 | 121,687 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock (Right to Buy) | Disposition | 2013-08-15 | 4,499 | $0.00 | 4,499 | $18.19 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
110,319 | 2013-08-15 | No | 4 | M | Direct |
Footnotes
- Options were granted on 8/15/2008, vested 20% each year on the anniversary date of the grant, and expire on 8/15/2013